Blood Test May Reduce Risk of Disability in Kids
An experimental blood test that reflects injury to nerve cells from multiple sclerosis (MS) was found to work for children with MS and other neurological conditions, even when they are symptom-free.
University of California San Francisco
Give to UCSFAn experimental blood test that reflects injury to nerve cells from multiple sclerosis (MS) was found to work for children with MS and other neurological conditions, even when they are symptom-free.
A rare burst of visual creativity is seen occasionally in patients with frontotemporal dementia. A UCSF-led study offers new insights into how this talent develops as key areas of the brain degenerate.
A large, collaborative study on multiple sclerosis (MS) severity found that a single gene variant is predictive of much faster neurodegeneration in MS patients.
UCSF Benioff Children’s Hospitals are recognized among the nation’s best pediatric medical centers in all 10 specialties assessed in U.S. News & World Report’s Best Children’s Hospitals 2023-24.
The advent of cheap, easy-to-use blood tests for Alzheimer’s disease has the potential to revolutionize diagnosis and treatment. But they also raise difficult questions that the field is only beginning to consider.
UCSF researchers developed an approach to measure an over-the-counter allergy medication’s effectiveness in repairing brain damage from multiple sclerosis (MS), making it possible to also assess future therapies for the disorder.
UCSF researchers discover how gabapentin interacts with calcium channels, opening doors for more effective treatments in epilepsy and Lupus by influencing channel biogenesis.
In a first, researchers have identified chronic pain pathways in individuals directly from their neural activity, showing promising paths forward for treatment.
Exposure to trichloroethylene (TCE), a chemical found in the air, water, and soil, may increase the risk of Parkinson's disease by 70%, according to a UCSF study. TCE is commonly used today as a degreasing solvent.
Saul Villeda, the 2023 recipient of the Byers Award, delivered a lecture titled "Blood Work and the Brain: Deciphering the Language of Cognitive Rejuvenation." His research focuses on understanding the biological mechanisms behind cognitive decline with age and exploring potential ways to reverse it.